TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Brain Metastases
Interventions: DRUG: Trastuzumab|DRUG: Taxanes|DRUG: Pertuzumab|DRUG: Tyrosine kinase inhibitor
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Peking University International Hospital|Sun Yat-sen University|Zhejiang University